Literature DB >> 21545152

Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1.

Kelly E Duncan1, Brian R Dempsey, Lauren E Killip, Jarrett Adams, Melanie L Bailey, Gilles A Lajoie, David W Litchfield, Christopher J Brandl, Gary S Shaw, Brian H Shilton.   

Abstract

Phage panning led to the discovery of a disulfide-cyclized peptide CRYPEVEIC that inhibits Pin1 activity with a K(I) of 0.5 μM. NMR chemical shift perturbation experiments show that cyclic CRYPEVEIC binds to the active site of Pin1. Pin1 residues K63 and R68, which bind the phosphate of substrate peptides, do not show a significant chemical shift change in response to binding of cyclic CRYPEVEIC, consistent with absence of phosphate on the peptide. Cyclic CRYPEVEIC adopts a stable conformation with the side chains of the Y, P, V, and I residues packed together on one side of the ring. Cyclic CRYPEVEIC in solution exists as a mixture of two species, with a 1:4 cis/trans ratio for the Y-P bond. This mixture is stabilized to a single conformation when bound to Pin1. The constrained structure of cyclic CRYPEVEIC apparently facilitates high affinity binding without the presence of a phosphate group.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21545152     DOI: 10.1021/jm200156c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

Review 1.  Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds.

Authors:  Bryan M Dunyak; Jason E Gestwicki
Journal:  J Med Chem       Date:  2016-07-25       Impact factor: 7.446

Review 2.  Prolyl isomerases in gene transcription.

Authors:  Steven D Hanes
Journal:  Biochim Biophys Acta       Date:  2014-10-31

3.  A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.

Authors:  Bisheng Jiang; Dehua Pei
Journal:  J Med Chem       Date:  2015-07-28       Impact factor: 7.446

4.  Generation of a cell-permeable cycloheptapeptidyl inhibitor against the peptidyl-prolyl isomerase Pin1.

Authors:  Walaa Bedewy; Hui Liao; Nageh A Abou-Taleb; Sherif F Hammad; Tamer Nasr; Dehua Pei
Journal:  Org Biomol Chem       Date:  2017-05-31       Impact factor: 3.876

5.  Pre-Anchoring of Pin1 to Unphosphorylated c-Myc in a Fuzzy Complex Regulates c-Myc Activity.

Authors:  Sara Helander; Meri Montecchio; Robert Pilstål; Yulong Su; Jacob Kuruvilla; Malin Elvén; Javed M E Ziauddin; Madhanagopal Anandapadamanaban; Susana Cristobal; Patrik Lundström; Rosalie C Sears; Björn Wallner; Maria Sunnerhagen
Journal:  Structure       Date:  2015-11-19       Impact factor: 5.006

Review 6.  The Ess1 prolyl isomerase: traffic cop of the RNA polymerase II transcription cycle.

Authors:  Steven D Hanes
Journal:  Biochim Biophys Acta       Date:  2014-02-12

7.  The prolyl isomerase pin1 regulates mRNA levels of genes with short half-lives by targeting specific RNA binding proteins.

Authors:  Nithya Krishnan; Mark A Titus; Roopa Thapar
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

Review 8.  Gears-In-Motion: The Interplay of WW and PPIase Domains in Pin1.

Authors:  Yew Mun Lee; Yih-Cherng Liou
Journal:  Front Oncol       Date:  2018-10-25       Impact factor: 6.244

9.  Non-catalytic participation of the Pin1 peptidyl-prolyl isomerase domain in target binding.

Authors:  Brendan T Innes; Melanie L Bailey; Christopher J Brandl; Brian H Shilton; David W Litchfield
Journal:  Front Physiol       Date:  2013-02-13       Impact factor: 4.566

10.  Pin1 is related with clinical stage of papillary thyroid carcinoma.

Authors:  Lixin Jiang; Haidi Chu; Haitao Zheng
Journal:  World J Surg Oncol       Date:  2016-03-31       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.